ZA200901015B - Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders - Google Patents

Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders

Info

Publication number
ZA200901015B
ZA200901015B ZA200901015A ZA200901015A ZA200901015B ZA 200901015 B ZA200901015 B ZA 200901015B ZA 200901015 A ZA200901015 A ZA 200901015A ZA 200901015 A ZA200901015 A ZA 200901015A ZA 200901015 B ZA200901015 B ZA 200901015B
Authority
ZA
South Africa
Prior art keywords
treatment
proliferative disorders
pyrimidine derivatives
derivatives useful
morpholino pyrimidine
Prior art date
Application number
ZA200901015A
Inventor
Maurice Raymond Verschoyle Finlay
Jeffrey Morris
Kurt Gordon Pike
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ZA200901015B publication Critical patent/ZA200901015B/en

Links

ZA200901015A 2006-08-24 2009-02-12 Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders ZA200901015B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0616747A GB0616747D0 (en) 2006-08-24 2006-08-24 Novel compounds

Publications (1)

Publication Number Publication Date
ZA200901015B true ZA200901015B (en) 2010-08-25

Family

ID=37102735

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200901015A ZA200901015B (en) 2006-08-24 2009-02-12 Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders

Country Status (7)

Country Link
CN (2) CN101541781B (en)
BR (1) BRPI0715609A2 (en)
ES (1) ES2393215T3 (en)
GB (1) GB0616747D0 (en)
RU (1) RU2440349C2 (en)
TW (1) TW200817384A (en)
ZA (1) ZA200901015B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2057156T1 (en) * 2006-08-23 2017-06-30 Kudos Pharmaceuticals Limited 2-methylmorpholine pyrido-,pyrazo- and pyrimido-pyrimidine derivatives as mtor inhibitors
US20120288492A1 (en) * 2009-12-28 2012-11-15 Dcb-Usa Llc NOVEL PYRIMIDINE COMPOUNDS AS mTOR AND PI3K INHIBITORS
UY33198A (en) * 2010-01-26 2011-08-31 Boehringer Ingelheim Int 5-ALQUINIL-PYRIMIDINS.
AR085406A1 (en) * 2011-02-25 2013-09-25 Takeda Pharmaceutical N-SUBSTITUTED OXAZINOPTERIDINS AND N-REPLACED OXAZINOPTERIDINONES
AU2012311458B2 (en) * 2011-09-21 2016-02-04 Cellzome Limited Morpholino substituted urea or carbamate derivatives as mTOR inhibitors
ES2624307T3 (en) 2012-05-15 2017-07-13 Cancer Research Technology Ltd 5 - [[4 - [[Morpholin-2-yl] methylamino] -5- (trifluoromethyl) -2-pyridyl] amino] pyrazin-2-carbonitrile and therapeutic uses thereof

Also Published As

Publication number Publication date
CN101558046A (en) 2009-10-14
ES2393215T3 (en) 2012-12-19
BRPI0715609A2 (en) 2013-10-08
TW200817384A (en) 2008-04-16
RU2440349C2 (en) 2012-01-20
RU2009110255A (en) 2010-09-27
GB0616747D0 (en) 2006-10-04
CN101541781B (en) 2014-01-08
CN101541781A (en) 2009-09-23

Similar Documents

Publication Publication Date Title
IL196998A0 (en) Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders
IL195731A0 (en) Pyrimidine derivatives useful in the treatment of cancer
IL195152A (en) Compounds for use in the treatment of cell proliferative disorders
IL192281A0 (en) Morpholino pyrimidine derivatives and their use in therapy
ZA201000106B (en) Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases
ZA201000087B (en) Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases
IL195906A0 (en) Alpha-aminoamide derivatives useful in the treatment of cognitive disorders
IL179508A0 (en) 2-substituted-4- heteroaryl-pyrimidines useful for the treatment of proliferative disorders
ZA200901593B (en) Pyrimidines derivatives and their use as kinase inhibitors
EP1853539A4 (en) Honokiol derivatives for the treatment of proliferative disorders
IL205108A0 (en) Pyridine and pyrazine derivatives useful in the treatment of cell proliferative disorders
HK1148284A1 (en) Isoxazolopyridine derivatives for use in the treatment of hif-mediated conditions hif
EP2063896A4 (en) Kinase inhibitors useful for the treatment of proliferative diseases
EP2146716A4 (en) Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
IL186939A0 (en) Pyrimidine derivatives and their use as
ZA200708591B (en) Pyrimidine derivatives for treatment of hyperproliferative disorders
PT2101731T (en) Endoxifen for use in the treatment of cancer
IL195900A0 (en) Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases
ZA201001264B (en) 1-amino-alkylcycohxane derivatives for the treatment of cochleat tinnitus
IL205578A0 (en) Aldh-2 inhibitors in the treatment of psychiatric disorders
EP1951681A4 (en) Novel 2-aminopyrimidine derivatives and their use
IL188390A0 (en) Imidazolyl-pyrimidine compounds for use in the treatment of proliferative disorders
ZA200901015B (en) Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders
HK1146221A1 (en) Alpha-aminoamide derivatives useful in the treatment of psychiatric disorders
ZA200902730B (en) Pteridine derivatives as polo-like kinase inhibitors useful in the treatment of cancer